Dissecting Structural and Functional Diversity of the Lantibiotic Mersacidin

被引:83
作者
Appleyard, Antony N. [1 ]
Choi, Shaila [1 ]
Read, Daniel M. [1 ]
Lightfoot, Ann [1 ,2 ,3 ]
Boakes, Steven [1 ]
Hoffmann, Anja [4 ]
Chopra, Ian [2 ,3 ]
Bierbaum, Gabriele [4 ]
Rudd, Brian A. M. [1 ]
Dawson, Michael J. [1 ]
Cortes, Jesus [1 ]
机构
[1] Novacta Biosyst Ltd, Welwyn Garden City AL7 3AX, Herts, England
[2] Univ Leeds, Antimicrobial Res Ctr, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England
[4] Univ Bonn, Inst Med Mikrobiol & Immunol, D-53105 Bonn, Germany
来源
CHEMISTRY & BIOLOGY | 2009年 / 16卷 / 05期
基金
英国惠康基金;
关键词
IN-VITRO RECONSTITUTION; PEPTIDOGLYCAN BIOSYNTHESIS; EXPRESSION SYSTEM; LEADER PEPTIDE; D-ALANINE; NISIN; PURIFICATION; MUTAGENESIS; SEQUENCE; LACTICIN-3147;
D O I
10.1016/j.chembiol.2009.03.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mersacidin is a tetracyclic lantibiotic with antibacterial activity against Gram-positive pathogens. To probe the specificity of the biosynthetic pathway of mersacidin and obtain analogs with improved antibacterial activity, an efficient system for generating variants of this lantibiotic was developed. A saturation mutagenesis library of the residues of mersacidin not involved in cycle formation was constructed and used to validate this system. Mersacidin analogs were obtained in good yield in approximately 35% of the cases, producing a collection of 82 new compounds. This system was also used for the production of deletion and insertion mutants of mersacidin. The outcome of these studies suggests that this system can be extended to produce mersacidin variants with multiple changes that will allow a full investigation of the potential use of modified mersacidins as therapeutic agents.
引用
收藏
页码:490 / 498
页数:9
相关论文
共 44 条
[1]   EPIDERMIN - SEQUENCING OF A HETERODET TETRACYCLIC 21-PEPTIDE AMIDE ANTIBIOTIC [J].
ALLGAIER, H ;
JUNG, G ;
WERNER, RG ;
SCHNEIDER, U ;
ZAHNER, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 160 (01) :9-22
[2]   Biosynthesis of the lantibiotic mersacidin: Organization of a type B lantibiotic gene cluster [J].
Altena, K ;
Guder, A ;
Cramer, C ;
Bierbaum, G .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (06) :2565-2571
[3]   GENETIC-ANALYSIS OF EPIDERMIN BIOSYNTHETIC GENES AND EPIDERMIN-NEGATIVE MUTANTS OF STAPHYLOCOCCUS-EPIDERMIDIS [J].
AUGUSTIN, J ;
ROSENSTEIN, R ;
WIELAND, B ;
SCHNEIDER, U ;
SCHNELL, N ;
ENGELKE, G ;
ENTIAN, KD ;
GOTZ, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 204 (03) :1149-1154
[4]   CLONING, SEQUENCING AND PRODUCTION OF THE LANTIBIOTIC MERSACIDIN [J].
BIERBAUM, G ;
BROTZ, H ;
KOLLER, KP ;
SAHL, HG .
FEMS MICROBIOLOGY LETTERS, 1995, 127 (1-2) :121-126
[5]   MODE OF ACTION OF THE LANTIBIOTIC MERSACIDIN - INHIBITION OF PEPTIDOGLYCAN BIOSYNTHESIS VIA A NOVEL MECHANISM [J].
BROTZ, H ;
BIERBAUM, G ;
MARKUS, A ;
MOLITOR, E ;
SAHL, HG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) :714-719
[6]   The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation [J].
Brotz, H ;
Bierbaum, G ;
Reynolds, PE ;
Sahl, HG .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 246 (01) :193-199
[7]   The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II [J].
Brötz, H ;
Bierbaum, G ;
Leopold, K ;
Reynolds, PE ;
Sahl, HG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (01) :154-160
[8]   Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens [J].
Castiglione, Franca ;
Lazzarini, Ameriga ;
Carrano, Lucia ;
Corti, Emiliana ;
Ciciliato, Ismaela ;
Gastaldo, Luciano ;
Candiani, Paolo ;
Losi, Daniele ;
Marinelli, Flavia ;
Selva, Enrico ;
Parenti, Francesco .
CHEMISTRY & BIOLOGY, 2008, 15 (01) :22-31
[9]   Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase [J].
Chatterjee, Champak ;
Patton, Gregory C. ;
Cooper, Lisa ;
Paul, Moushumi ;
van der Donk, Wilfred A. .
CHEMISTRY & BIOLOGY, 2006, 13 (10) :1109-1117
[10]   MERSACIDIN, A NEW ANTIBIOTIC FROM BACILLUS INVITRO AND INVIVO ANTIBACTERIAL ACTIVITY [J].
CHATTERJEE, S ;
CHATTERJEE, DK ;
JANI, RH ;
BLUMBACH, J ;
GANGULI, BN ;
KLESEL, N ;
LIMBERT, M ;
SEIBERT, G .
JOURNAL OF ANTIBIOTICS, 1992, 45 (06) :839-845